Spoken Alpha
Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering develops immunotherapy product candidates for treating cancer. The development-stage biotechnology company is pursuing new product candidates and platforms based on its understanding of immunotherapies, and is seeking to license or acquire clinical-stage cancer therapies and related technologies to build its pipeline.
Mosaic ImmunoEngineering Inc is a Healthcare company operating in Biotechnology with a $441,770 market cap.
Most recent reported earnings: Q2 FY2026 (Jun 29, 2026).
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add CPMV, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CPMV.
$ curl https://api.spokenalpha.com/v1/companies/CPMVFAQ
Spoken Alpha indexes CPMV's earnings call transcripts at https://spokenalpha.com/companies/CPMV. Each call links to attributed speakers and parsed analyst Q&A. Mosaic ImmunoEngineering Inc.'s own investor relations page is at https://www.mosaicie.com/investors.
Mosaic ImmunoEngineering Inc. (CPMV) operates in the Healthcare sector (Biotechnology industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-06-29 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-03-30 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q4 FY2025 | 2025-12-30 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-18 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-18 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-11 | $-0.03 | — | — | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-01-13 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-10-31 | $-0.03 | — | — | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-04 | $-0.04 | — | — | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-13 | $-0.04 | — | — | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-01-08 | $-0.04 | — | — | $0 | — | — | EODHD |
| Q3 FY2023 | 2023-11-01 | $-0.05 | $0.00 | — | — | — | — | EODHD |
| Q2 FY2023 | 2023-08-14 | $0.00 | — | — | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-11 | $-0.06 | $0.00 | — | — | — | — | EODHD |
| Q4 FY2022 | 2023-01-09 | $-0.07 | — | — | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-10-09 | $-0.02 | — | — | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-15 | $-0.13 | — | — | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-04-10 | $-0.11 | — | — | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-01-10 | $-0.12 | — | — | $0 | — | — | EODHD |
| Q3 FY2021 | 2021-10-10 | $-0.15 | — | — | $0 | — | — | EODHD |
Source: EODHD. CPMV reported actuals as published; sparse fields render as —.